HEADER HYDROLASE 17-MAY-16 5JZS TITLE HSAD BOUND TO 3,5-DICHLORO-4-HYDROXYBENZOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE BPHD; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HSAD; COMPND 5 EC: 3.7.1.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: BPHD, AFL40_3716, BN1213_03918, BN1303_03049, ERS007661_00365, SOURCE 5 ERS007663_01172, ERS007665_00879, ERS007670_01859, ERS007679_00575, SOURCE 6 ERS007722_01141, ERS007741_03068, ERS013471_01596, ERS024213_01658, SOURCE 7 ERS027646_02381, ERS027654_01339, ERS027656_01041, ERS027661_00436, SOURCE 8 ERS124361_01169; SOURCE 9 EXPRESSION_SYSTEM: PSEUDOMONAS PUTIDA; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 303; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: KT2442; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PVLT31 KEYWDS HSAD, INHIBITOR, M. TUBERCULOSIS, CHOLESTEROL, INFECTION, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.RYAN,E.POLYCARPOU,N.LACK,D.EVANGELOPOULOS,C.SIEG,A.HALMAN,S.BHAKTA, AUTHOR 2 A.SINCLAIR,O.ELEFTHERIADOU,T.D.MCHUGH,S.KEANY,E.D.LOWE,R.BALLET, AUTHOR 3 A.ABUHAMMAD,A.CIULLI,E.SIM REVDAT 4 10-JAN-24 5JZS 1 REMARK ATOM REVDAT 3 05-JUL-17 5JZS 1 JRNL REVDAT 2 12-APR-17 5JZS 1 JRNL REVDAT 1 05-APR-17 5JZS 0 JRNL AUTH A.RYAN,E.POLYCARPOU,N.A.LACK,D.EVANGELOPOULOS,C.SIEG, JRNL AUTH 2 A.HALMAN,S.BHAKTA,O.ELEFTHERIADOU,T.D.MCHUGH,S.KEANY, JRNL AUTH 3 E.D.LOWE,R.BALLET,A.ABUHAMMAD,W.R.JACOBS,A.CIULLI,E.SIM JRNL TITL INVESTIGATION OF THE MYCOBACTERIAL ENZYME HSAD AS A JRNL TITL 2 POTENTIAL NOVEL TARGET FOR ANTI-TUBERCULAR AGENTS USING A JRNL TITL 3 FRAGMENT-BASED DRUG DESIGN APPROACH. JRNL REF BR. J. PHARMACOL. V. 174 2209 2017 JRNL REFN ISSN 1476-5381 JRNL PMID 28380256 JRNL DOI 10.1111/BPH.13810 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 97.57 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.910 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 29210 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1484 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 97.6552 - 5.0485 0.99 2806 156 0.1698 0.1830 REMARK 3 2 5.0485 - 4.0071 0.99 2669 161 0.1410 0.1803 REMARK 3 3 4.0071 - 3.5005 0.98 2613 142 0.1654 0.2076 REMARK 3 4 3.5005 - 3.1804 0.98 2610 127 0.2060 0.2380 REMARK 3 5 3.1804 - 2.9525 0.98 2577 136 0.2156 0.2678 REMARK 3 6 2.9525 - 2.7784 0.96 2567 124 0.2411 0.2692 REMARK 3 7 2.7784 - 2.6392 0.94 2456 139 0.2712 0.3217 REMARK 3 8 2.6392 - 2.5243 0.93 2460 133 0.2993 0.3955 REMARK 3 9 2.5243 - 2.4271 0.92 2430 125 0.3156 0.3980 REMARK 3 10 2.4271 - 2.3434 0.88 2352 122 0.3395 0.3775 REMARK 3 11 2.3434 - 2.2701 0.84 2186 119 0.3982 0.4261 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4515 REMARK 3 ANGLE : 1.221 6118 REMARK 3 CHIRALITY : 0.078 659 REMARK 3 PLANARITY : 0.006 806 REMARK 3 DIHEDRAL : 15.455 1633 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND SEGID REMARK 3 SELECTION : CHAIN B AND SEGID REMARK 3 ATOM PAIRS NUMBER : 2623 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5JZS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-MAY-16. REMARK 100 THE DEPOSITION ID IS D_1000221510. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97630 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.1.27 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30015 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 97.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.72600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2VF2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% (W/V) PEG-3000, 0.1M CHES PH 9.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.96000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 97.56500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.13500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 97.56500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.96000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.13500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 40.96000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.13500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 97.56500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.13500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 40.96000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 97.56500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -41.13500 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 355 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 372 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 376 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 17 CD OE1 OE2 REMARK 470 LYS A 25 CG CD CE NZ REMARK 470 ASP A 36 CG OD1 OD2 REMARK 470 GLU A 168 CG CD OE1 OE2 REMARK 470 ARG A 230 NE CZ NH1 NH2 REMARK 470 ARG A 258 CZ NH1 NH2 REMARK 470 GLU B 10 CG CD OE1 OE2 REMARK 470 LYS B 25 CD CE NZ REMARK 470 GLU B 84 CD OE1 OE2 REMARK 470 LYS B 160 CD CE NZ REMARK 470 GLU B 168 CD OE1 OE2 REMARK 470 GLN B 191 CG CD OE1 NE2 REMARK 470 GLU B 200 CD OE1 OE2 REMARK 470 ARG B 206 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 210 CG CD CE NZ REMARK 470 LYS B 281 CE NZ REMARK 470 GLU B 285 CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS B 181 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 81 75.60 -108.91 REMARK 500 SER A 114 -118.55 54.91 REMARK 500 ARG A 258 45.12 -107.54 REMARK 500 LYS B 81 74.44 -107.69 REMARK 500 SER B 114 -119.90 59.22 REMARK 500 VAL B 243 -60.84 -99.45 REMARK 500 ARG B 258 45.90 -104.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FGZ B 1000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VF2 RELATED DB: PDB REMARK 900 APO ENZYME REMARK 900 RELATED ID: 5JZ9 RELATED DB: PDB REMARK 900 HSAD WITH ANOTHER INHIBITOR REMARK 900 RELATED ID: 5JZB RELATED DB: PDB REMARK 900 HSAD WITH ANOTHER INHIBITOR DBREF1 5JZS A 7 290 UNP A0A045KDP6_MYCTX DBREF2 5JZS A A0A045KDP6 7 290 DBREF1 5JZS B 7 290 UNP A0A045KDP6_MYCTX DBREF2 5JZS B A0A045KDP6 7 290 SEQRES 1 A 284 LEU THR PHE GLU SER THR SER ARG PHE ALA GLU VAL ASP SEQRES 2 A 284 VAL ASP GLY PRO LEU LYS LEU HIS TYR HIS GLU ALA GLY SEQRES 3 A 284 VAL GLY ASN ASP GLN THR VAL VAL LEU LEU HIS GLY GLY SEQRES 4 A 284 GLY PRO GLY ALA ALA SER TRP THR ASN PHE SER ARG ASN SEQRES 5 A 284 ILE ALA VAL LEU ALA ARG HIS PHE HIS VAL LEU ALA VAL SEQRES 6 A 284 ASP GLN PRO GLY TYR GLY HIS SER ASP LYS ARG ALA GLU SEQRES 7 A 284 HIS GLY GLN PHE ASN ARG TYR ALA ALA MET ALA LEU LYS SEQRES 8 A 284 GLY LEU PHE ASP GLN LEU GLY LEU GLY ARG VAL PRO LEU SEQRES 9 A 284 VAL GLY ASN SER LEU GLY GLY GLY THR ALA VAL ARG PHE SEQRES 10 A 284 ALA LEU ASP TYR PRO ALA ARG ALA GLY ARG LEU VAL LEU SEQRES 11 A 284 MET GLY PRO GLY GLY LEU SER ILE ASN LEU PHE ALA PRO SEQRES 12 A 284 ASP PRO THR GLU GLY VAL LYS ARG LEU SER LYS PHE SER SEQRES 13 A 284 VAL ALA PRO THR ARG GLU ASN LEU GLU ALA PHE LEU ARG SEQRES 14 A 284 VAL MET VAL TYR ASP LYS ASN LEU ILE THR PRO GLU LEU SEQRES 15 A 284 VAL ASP GLN ARG PHE ALA LEU ALA SER THR PRO GLU SER SEQRES 16 A 284 LEU THR ALA THR ARG ALA MET GLY LYS SER PHE ALA GLY SEQRES 17 A 284 ALA ASP PHE GLU ALA GLY MET MET TRP ARG GLU VAL TYR SEQRES 18 A 284 ARG LEU ARG GLN PRO VAL LEU LEU ILE TRP GLY ARG GLU SEQRES 19 A 284 ASP ARG VAL ASN PRO LEU ASP GLY ALA LEU VAL ALA LEU SEQRES 20 A 284 LYS THR ILE PRO ARG ALA GLN LEU HIS VAL PHE GLY GLN SEQRES 21 A 284 CYS GLY HIS TRP VAL GLN VAL GLU LYS PHE ASP GLU PHE SEQRES 22 A 284 ASN LYS LEU THR ILE GLU PHE LEU GLY GLY GLY SEQRES 1 B 284 LEU THR PHE GLU SER THR SER ARG PHE ALA GLU VAL ASP SEQRES 2 B 284 VAL ASP GLY PRO LEU LYS LEU HIS TYR HIS GLU ALA GLY SEQRES 3 B 284 VAL GLY ASN ASP GLN THR VAL VAL LEU LEU HIS GLY GLY SEQRES 4 B 284 GLY PRO GLY ALA ALA SER TRP THR ASN PHE SER ARG ASN SEQRES 5 B 284 ILE ALA VAL LEU ALA ARG HIS PHE HIS VAL LEU ALA VAL SEQRES 6 B 284 ASP GLN PRO GLY TYR GLY HIS SER ASP LYS ARG ALA GLU SEQRES 7 B 284 HIS GLY GLN PHE ASN ARG TYR ALA ALA MET ALA LEU LYS SEQRES 8 B 284 GLY LEU PHE ASP GLN LEU GLY LEU GLY ARG VAL PRO LEU SEQRES 9 B 284 VAL GLY ASN SER LEU GLY GLY GLY THR ALA VAL ARG PHE SEQRES 10 B 284 ALA LEU ASP TYR PRO ALA ARG ALA GLY ARG LEU VAL LEU SEQRES 11 B 284 MET GLY PRO GLY GLY LEU SER ILE ASN LEU PHE ALA PRO SEQRES 12 B 284 ASP PRO THR GLU GLY VAL LYS ARG LEU SER LYS PHE SER SEQRES 13 B 284 VAL ALA PRO THR ARG GLU ASN LEU GLU ALA PHE LEU ARG SEQRES 14 B 284 VAL MET VAL TYR ASP LYS ASN LEU ILE THR PRO GLU LEU SEQRES 15 B 284 VAL ASP GLN ARG PHE ALA LEU ALA SER THR PRO GLU SER SEQRES 16 B 284 LEU THR ALA THR ARG ALA MET GLY LYS SER PHE ALA GLY SEQRES 17 B 284 ALA ASP PHE GLU ALA GLY MET MET TRP ARG GLU VAL TYR SEQRES 18 B 284 ARG LEU ARG GLN PRO VAL LEU LEU ILE TRP GLY ARG GLU SEQRES 19 B 284 ASP ARG VAL ASN PRO LEU ASP GLY ALA LEU VAL ALA LEU SEQRES 20 B 284 LYS THR ILE PRO ARG ALA GLN LEU HIS VAL PHE GLY GLN SEQRES 21 B 284 CYS GLY HIS TRP VAL GLN VAL GLU LYS PHE ASP GLU PHE SEQRES 22 B 284 ASN LYS LEU THR ILE GLU PHE LEU GLY GLY GLY HET FGZ B1000 12 HETNAM FGZ 3,5-DICHLORO-4-HYDROXYBENZOIC ACID FORMUL 3 FGZ C7 H4 CL2 O3 FORMUL 4 HOH *130(H2 O) HELIX 1 AA1 THR A 8 THR A 12 1 5 HELIX 2 AA2 ALA A 50 SER A 56 1 7 HELIX 3 AA3 ASN A 58 ARG A 64 1 7 HELIX 4 AA4 GLN A 87 GLY A 104 1 18 HELIX 5 AA5 SER A 114 TYR A 127 1 14 HELIX 6 AA6 THR A 152 ALA A 164 1 13 HELIX 7 AA7 THR A 166 VAL A 176 1 11 HELIX 8 AA8 ASP A 180 ILE A 184 5 5 HELIX 9 AA9 THR A 185 SER A 197 1 13 HELIX 10 AB1 THR A 198 ALA A 213 1 16 HELIX 11 AB2 ASP A 216 LEU A 229 5 14 HELIX 12 AB3 PRO A 245 GLY A 248 5 4 HELIX 13 AB4 ALA A 249 ILE A 256 1 8 HELIX 14 AB5 TRP A 270 LYS A 275 1 6 HELIX 15 AB6 LYS A 275 LEU A 287 1 13 HELIX 16 AB7 THR B 8 THR B 12 1 5 HELIX 17 AB8 ALA B 50 PHE B 55 1 6 HELIX 18 AB9 PHE B 55 ARG B 64 1 10 HELIX 19 AC1 GLN B 87 GLY B 104 1 18 HELIX 20 AC2 SER B 114 TYR B 127 1 14 HELIX 21 AC3 THR B 152 ALA B 164 1 13 HELIX 22 AC4 THR B 166 VAL B 176 1 11 HELIX 23 AC5 ASP B 180 ILE B 184 5 5 HELIX 24 AC6 THR B 185 SER B 197 1 13 HELIX 25 AC7 THR B 198 SER B 211 1 14 HELIX 26 AC8 PHE B 212 GLY B 214 5 3 HELIX 27 AC9 ASP B 216 LEU B 229 5 14 HELIX 28 AD1 PRO B 245 GLY B 248 5 4 HELIX 29 AD2 ALA B 249 ILE B 256 1 8 HELIX 30 AD3 TRP B 270 LYS B 275 1 6 HELIX 31 AD4 LYS B 275 LEU B 287 1 13 SHEET 1 AA1 8 SER A 13 ASP A 19 0 SHEET 2 AA1 8 PRO A 23 ALA A 31 -1 O LEU A 26 N ALA A 16 SHEET 3 AA1 8 HIS A 67 VAL A 71 -1 O ALA A 70 N HIS A 29 SHEET 4 AA1 8 THR A 38 LEU A 42 1 N VAL A 39 O HIS A 67 SHEET 5 AA1 8 VAL A 108 ASN A 113 1 O VAL A 111 N LEU A 42 SHEET 6 AA1 8 ALA A 131 MET A 137 1 O VAL A 135 N LEU A 110 SHEET 7 AA1 8 VAL A 233 GLY A 238 1 O ILE A 236 N LEU A 136 SHEET 8 AA1 8 ALA A 259 PHE A 264 1 O GLN A 260 N LEU A 235 SHEET 1 AA2 8 SER B 13 ASP B 19 0 SHEET 2 AA2 8 PRO B 23 ALA B 31 -1 O LEU B 26 N ALA B 16 SHEET 3 AA2 8 PHE B 66 VAL B 71 -1 O ALA B 70 N HIS B 29 SHEET 4 AA2 8 GLN B 37 LEU B 42 1 N GLN B 37 O HIS B 67 SHEET 5 AA2 8 VAL B 108 ASN B 113 1 O VAL B 111 N LEU B 42 SHEET 6 AA2 8 ALA B 131 MET B 137 1 O VAL B 135 N GLY B 112 SHEET 7 AA2 8 VAL B 233 GLY B 238 1 O LEU B 234 N LEU B 134 SHEET 8 AA2 8 ALA B 259 PHE B 264 1 O HIS B 262 N LEU B 235 CISPEP 1 ASP A 150 PRO A 151 0 -0.75 CISPEP 2 ASP B 150 PRO B 151 0 0.05 SITE 1 AC1 9 GLY B 45 GLY B 46 SER B 114 LEU B 115 SITE 2 AC1 9 GLY B 154 VAL B 155 LEU B 158 VAL B 243 SITE 3 AC1 9 HOH B1137 CRYST1 81.920 82.270 195.130 90.00 90.00 90.00 I 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012207 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005125 0.00000